NASDAQ:DRUG - Nasdaq - CA10919W4056 - Common Stock - Currency: USD
MRQ (2025-3-31) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
---|---|---|---|---|---|---|---|---|
ASSETS | ||||||||
Current Assets | ||||||||
Cash | 55.59M | 5.63M | N/A | N/A | 19.76M | |||
Cash Equivalents | 86.20K | 86.20K | N/A | N/A | N/A | |||
Receivables | 233.60K | 50.20K | N/A | N/A | 110.20K | |||
Other Current Assets | 401.40K | 216.60K | N/A | N/A | 168.20K | |||
Total Current Assets | 56.31M | 5.99M | N/A | N/A | 20.04M | |||
Non-Current Assets | ||||||||
PPE Net | 154.50K | 117.70K | N/A | N/A | N/A | |||
Intangibles | N/A | N/A | N/A | N/A | 2.00K | |||
Total Non-Current Assets | 154.50K | 117.70K | N/A | N/A | 2.00K | |||
TOTAL ASSETS | 56.47M | 6.10M | N/A | N/A | 20.04M | |||
LIABILITIES | ||||||||
Current Liabilities | ||||||||
Short Term Debt | 0.00 | 0.00 | N/A | N/A | 0.00 | |||
Current Portion Of LT Debt. | 77.80K | 79.40K | N/A | N/A | N/A | |||
Accrued Expenses | 9.00K | 41.80K | N/A | N/A | 42.00K | |||
Accounts Payable | 551.20K | 407.60K | N/A | N/A | 596.60K | |||
Total Current Liabilities | 638.00K | 528.70K | N/A | N/A | 638.60K | |||
Non-Current Liabilities | ||||||||
Long Term Debt | 88.90K | 39.60K | N/A | N/A | 0.00 | |||
Total Non-Current Liabilities | 88.80K | 39.60K | N/A | N/A | 0.00 | |||
TOTAL LIABILITIES | 726.80K | 568.30K | N/A | N/A | 638.60K | |||
SHAREHOLDERS' EQUITY | ||||||||
Retained Earnings | -34.15M | -29.89M | N/A | N/A | -7.64M | |||
Common Shares | 89.89M | 35.42M | N/A | N/A | 27.08M | |||
Other Shareholders' Equity | N/A | N/A | N/A | N/A | -33.70K | |||
Shares Outstanding | 7.08M | 4.52M | N/A | N/A | 2.37M | |||
Tangible Book Value per Share | 7.87 | 1.22 | N/A | N/A | 8.20 | |||
Total Shareholders' Equity | 55.74M | 5.54M | N/A | N/A | 19.40M | |||
TOTAL LIABILITIES AND EQUITY | 56.47M | 6.10M | N/A | N/A | 20.04M | |||
Statistics | ||||||||
Debt/Equity | 0.00 | 0.01 | N/A | N/A | N/A | |||
Current Ratio | 88.27 | 11.32 | N/A | N/A | 31.38 | |||
Return On Assets (ROA) | -6.10% | -45.90% | N/A | N/A | -43.17% | |||
Return On Equity (ROE) | -6.18% | -50.61% | N/A | N/A | -44.59% |
All data in CAD , ROIC based on taxRate of 0.21